Boston Scientific Corp (BSX)
12.91USD
5 Dec 2014
$0.13 (+1.02%)
$12.78
$12.78
$12.92
$12.75
6,528,144
--
--
--
BSX
About
Overall
| Beta: | 1.05 |
| Market Cap (Mil.): | $16,952.54 |
| Shares Outstanding (Mil.): | 1,326.49 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BSX | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 59.13 | 33.08 | 39.27 |
| EPS (TTM): | 0.22 | -- | -- |
| ROI: | 1.93 | 7.93 | 17.35 |
| ROE: | 4.34 | 12.87 | 18.28 |
Transvaginal mesh trial losses put pressure on Boston Scientific
NEW YORK - Boston Scientific Corp’s back-to-back losses in the first two federal trials over its transvaginal mesh devices could drive up the cost of resolving thousands of similar lawsuits, according to legal experts.
Boston Scientific to pay $18.5 million in mesh case
NEW YORK - Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs’ lawyer said, in the third courtroom loss for the company over the products.
UPDATE 2-Boston Scientific to pay $18.5 mln in mesh case
NEW YORK, Nov 20 - Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs' lawyer said, in the third courtroom loss for the company over the products.
J&J demands $7.2 billion from Boston Scientific as trial begins
NEW YORK - Boston Scientific Corp should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly nine years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge on Thursday.
J&J demands $7.2 bln from Boston Scientific as trial begins
NEW YORK, Nov 20 - Boston Scientific Corp should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly nine years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge on Thursday.
Boston Scientific ordered to pay $14.5 mln for transvaginal mesh injuries
NEW YORK, Nov 20 - Boston Scientific Corp was ordered Thursday to pay $14.5 million for injuries caused by transvaginal mesh devices and may face millions of dollars in additional damages, in the third courtroom loss for the company over the devices, a plaintiffs' lawyer said.
Boston Scientific stent succeeds in study aimed at U.S. approval
CHICAGO, Nov 19 - Boston Scientific Corp's next generation Synergy heart stent succeeded in a pivotal study that will be used to seek U.S. and Japanese approval of the device, according to data presented at the American Heart Association meeting in Chicago on Wednesday.
BUSINESS-NEWS-SCHEDULE AT 1630 GMT /11:30 AM ET
(Adds CHICAGO/WASHINGTON story schedule, adds PIX to Keystone story)
BUSINESS-NEWS-SCHEDULE AT 1600 GMT /11:00 AM ET
Could Obama cut deal on Keystone pipeline? Don't rule it out
RPT-J&J seeks over $5 bln in damages from Boston Scientific at trial
NEW YORK, Nov 19 - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp , Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
Competitors
| Price | Change | |
|---|---|---|
| Abbott Laboratories (ABT.N) | $45.30 | -0.19 |
| Medtronic, Inc. (MDT.N) | $75.04 | +1.10 |
| St. Jude Medical, Inc. (STJ.N) | $69.95 | +0.62 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (BSX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$20.00
|
|
Provider: New Constructs, LLC
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: Directors Deals Ltd.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
